Please enter the email address you used to register, then we will send you a link to choose a new password
Actinium Pharmaceuticals (AMEX:ATNM) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.43) by 11.63 percent.
Posted In: ATNM